What is the appropriate management for a 7-year-old male with mixed nephrotic‑nephritic syndrome secondary to confirmed IgA nephropathy presenting with oliguria, hematuria, and generalized edema?

Management of Mixed Nephrotic-Nephritic Syndrome Secondary to IgA Nephropathy in a 7-Year-Old

This child requires immediate supportive care with diuretics and fluid management, followed by corticosteroid therapy given the acute presentation with nephrotic syndrome, oliguria, and generalized edema.

Immediate Supportive Management

Fluid and Edema Control

• Initiate furosemide at 0.5–2 mg/kg per dose intravenously or orally up to six times daily (maximum 10 mg/kg per day) based on the degree of edema and achieved diuresis 1.
• Administer doses over 5–30 minutes to minimize ototoxicity, and avoid high doses (>6 mg/kg/day) for periods longer than 1 week 1.
• Monitor closely for signs of hypovolemia (poor peripheral perfusion, hypotension, hyponatremia) before each diuretic dose, as oliguria may reflect intravascular volume depletion rather than fluid overload 1.
• Restrict dietary sodium to <2.0 g/day (<90 mmol/day) 1.
• If diuretic resistance develops, consider adding a thiazide diuretic or amiloride (preferred over spironolactone as an ENaC blocker) for synergistic effect 1.

Monitoring for Complications

• Assess for thrombotic complications given the nephrotic state with severe hypoalbuminemia and oliguria 1.
• Monitor blood pressure closely; target <120/70 mm Hg with antihypertensive therapy if needed 2.
• Evaluate renal function (eGFR), electrolytes (potassium, sodium), and fluid status daily during acute phase 1.

Immunosuppressive Therapy

Corticosteroid Treatment

Given the acute presentation with nephrotic syndrome in a child with IgA nephropathy, initiate oral prednisone at 60 mg/m² per day (maximum 60 mg) as a single daily dose 1, 3, 4.

The rationale for corticosteroid therapy includes:

• This child presents with features suggesting both IgA nephropathy and minimal change-like nephrotic syndrome, a recognized subset that responds to steroids 4, 5, 6.
• The sudden onset of generalized edema with heavy proteinuria and oliguria suggests a steroid-responsive component 4.
• Pediatric IgA nephropathy with nephrotic syndrome, particularly with acute presentation, may have wide foot process effacement on biopsy and respond favorably to corticosteroids 4, 6.

Treatment Duration and Monitoring

• Continue daily prednisone until remission is achieved (proteinuria <200 mg/g or trace/negative on dipstick for 3 consecutive days) 1.
• After achieving remission, transition to 40 mg/m² on alternate days for 6 weeks, then taper by 10 mg/m² per week 1.
• Total treatment duration should be approximately 12–16 weeks 1.
• Consider methylprednisolone pulse therapy (3 courses) if response to oral steroids is inadequate, as successfully used in pediatric IgA-dominant cases 3.

Additional Considerations

Adjunctive Immunosuppression

• If the patient shows steroid resistance or develops steroid toxicity, consider adding cyclosporine or tacrolimus as second-line therapy 1, 6.
• Cyclosporine combined with corticosteroids has shown efficacy in IgA nephropathy with MPGN-pattern lesions presenting as nephrotic syndrome 6.
• Mizoribine may be considered as an alternative immunosuppressive agent, particularly in Asian populations where it has demonstrated benefit 3.

Renin-Angiotensin System Blockade

• Initiate an ACE inhibitor (e.g., lisinopril) or ARB once hemodynamically stable to reduce proteinuria and provide long-term renoprotection 3, 2.
• This should be continued long-term regardless of immunosuppressive therapy response 2.

Critical Pitfalls to Avoid

• Do not assume oliguria indicates fluid overload—assess intravascular volume status carefully before aggressive diuresis, as hypovolemia can worsen renal function and increase thrombotic risk 1.
• Do not delay corticosteroid therapy while awaiting complete remission of edema; the nephrotic component may be steroid-responsive and delay worsens outcomes 4.
• Do not use spironolactone as first-line potassium-sparing diuretic—amiloride is preferred as it directly blocks ENaC, which is activated by urinary proteases in nephrotic syndrome 1.
• Monitor for infection risk given immunosuppression and nephrotic state; consider prophylactic antibiotics if severe hypoalbuminemia persists 1.

Prognostic Considerations

• Children with IgA nephropathy presenting with steroid-responsive nephrotic syndrome have excellent prognosis with none progressing to end-stage renal disease in reported series 4.
• Relapses may occur (reported in 42% of cases) but typically respond to repeat steroid courses 4.
• The mixed nephrotic-nephritic presentation requires aggressive early treatment to prevent incomplete recovery of renal function 3.